KLK3 and prostate carcinoma: Several proteins are already incorporated into disease risk stratification models such as measurements of lipids for Coronary Heart Disease (CHD)3,4 prediction or Prostate Specific Antigen (PSA) antigen for prostate cancer screening guidance5.